Microbial Resistance and Drug Discovery
The Van der Henst lab focuses on multidrug-resistant bacteria, with a clear emphasis on the Gram-negative bacterium Acinetobacter baumannii.
The Van der Henst lab focuses on multidrug-resistant bacteria, with a clear emphasis on the Gram-negative bacterium Acinetobacter baumannii. This nosocomial pathogen possesses a worrying and well-supplied resistance arsenal. In addition to increasing antibiotic resistances, A. baumannii thrives within hospital settings, relying on its resistances against disinfection procedures and environmental stresses. On top of that, A. baumannii virulence deserves to be better characterized. We aim to better understand the resistance and virulence arsenals of A. baumannii, while in parallel dedicating efforts in impairing them.
"Better understand to better fight"
A. baumannii strain collection of current MDR clinical isolates
To showcase the world-class scientific research of the Charles Van der Henst Lab, you can discover their scientific papers in more detail.
We are always on the lookout for highly motivated colleagues to join our team. If you are interested, please contact us.
The Charles Van der Henst Lab can only thrive thanks to the dedication and commitment of its people, no matter what their function or seniority.
To stay up to date in rapidly developing fields, scientists regularly interact with (international) colleagues. Conferences and other (scientific) events are an excellent way to facilitate such a continent-spanning knowledge exchange.